EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Clinical and Biochemical Outcomes of Super‐Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta‐Analysis

Qinxian Tu iD, Yizhuo Duan, Xiongjing Jiang, Hui Dong iD, Yubao Zou

The Journal of Clinical Hypertension · 2025

DOI: 10.1111/jch.70088 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Qinxian Tu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National Center for Cardiovascular Diseases Fuwai Hospital, Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Hyperaldosteronism, Embolization, Therapeutic, Adrenal Glands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review and meta‐analysis study evaluated the clinical and biochemical efficacy of super‐selective adrenal artery embolization (SAAE) in patients with primary aldosteronism (PA). The primary outcome was the change in office blood pressure, while secondary outcomes included changes in plasma aldosterone and serum potassium levels following the procedure. A systematic search of Embase, PubMed, Ovid, Web of Science, China National Knowledge Infrastructure, Wanfang, and SinoMed was conducted through December 14, 2024. Seventeen studies involving 650 patients (aged 28–65 years) with a median follow‐up of 6 months were included. Meta‐analysis, subgroup analysis, publication bias assessment, and sensitivity analysis were performed using RevMan 5.3 and R 4.2.3. The results showed that SAAE significantly reduced systolic (MD = −19.84 mmHg, 95% CI: −22.87 to −16.82 mmHg) and diastolic blood pressure (MD = −10.62 mmHg, 95% CI: −12.61 to −8.64 mmHg), lowered plasma aldosterone levels (MD = −90.99 pg/mL, 95% CI: −119.36 to −62.63 pg/mL), and increased serum potassium levels (MD = 0.59 mmol/L, 95% CI: 0.49–0.70 mmol/L). Subgroup analyses confirmed benefits in patients with both idiopathic hyperaldosteronism and aldosterone‐producing adenoma. These findings support SAAE as an effective treatment for improving clinical outcomes and correcting biochemical abnormalities in PA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismEmbolization, TherapeuticAdrenal GlandsHumansAldosteronePotassiumBlood PressureTreatment OutcomeAdultMiddle AgedFemaleMaleHypertension

Stichwörter der Autor:innen

hypertensionprimary aldosteronismtherapeutic embolization

Substanzen

AldosteronePotassium

Autor:innen und Institutionen

  • Department of Cardiology, National Center for Cardiovascular Diseases Fuwai Hospital, Peking Union Medical College, Beijing, China.

ORCID-Profile: Qinxian Tu, Hui Dong

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tu, Q., Duan, Y., Jiang, X., Dong, H., & Zou, Y. (2025). Clinical and Biochemical Outcomes of Super‐Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta‐Analysis. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70088

Vancouver

Tu Q, Duan Y, Jiang X, Dong H, Zou Y. Clinical and Biochemical Outcomes of Super‐Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta‐Analysis. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70088

BibTeX
@article{Tu2025,
  author = {Tu, Qinxian and Duan, Yizhuo and Jiang, Xiongjing and Dong, Hui and Zou, Yubao},
  title = {Clinical and Biochemical Outcomes of Super‐Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta‐Analysis},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  doi = {10.1111/jch.70088}
}
Kostenlos starten →